update
-
The purchase of Veritas by Swan Energy proved to be a windfall for investors in Veritas. I initially highlighted this stock on my blog when its trading price was approximately 139. Since then, it has experienced an impressive surge of nearly 225%, resulting in substantial profits for those who invested. Previous Articles: link1, link2, link3 Read more
-
As anticipated and elaborated in the previous update, the stock price of BHEL has surpassed the 180 mark, yielding a remarkable profit of 135% in under six months. At the current levels, it is advisable to consider securing partial gains and adopting a cautious approach. It is prudent to observe the market dynamics and wait… Read more
-
Having surpassed the significant overhead resistance at 275, the stock retraced temporarily but rebounded to reach 354, yielding an impressive 150% profit return from our initial entry point. This success has reinstated my confidence in the validity of the VCP (Volatility Contraction Pattern) and its effectiveness. For additional insights into the trade setup, please refer… Read more
-
BHEL emerged as a standout performer, breaking from a broadening wedge pattern and subsequently retesting it. Highlighted at a price of 79, the stock has followed the anticipated trajectory, reaching today’s peak at 165 and delivering a multi-bagger return. Despite the lackluster performance in the last quarter results, I chose to hold on to my… Read more
-
Following its breakout from a range that persisted for approximately four and a half years, Lincoln Pharma experienced the anticipated upward momentum, surging to 692 and yielding a profit of nearly 80% from the discussed levels. Pervious Blog post: link Read more